(23)Net Revenues
Net revenues are mainly generated from the sale of goods.
The distribution of net consolidated revenues for 2017, 2016 and 2015 by segment is as follows:
|
|
|
Thousands of Euros |
|
||||
|
|
|
31/12/2017 |
|
31/12/2016 |
|
31/12/2015 |
|
|
Bioscience |
|
3,429,785 |
|
3,195,424 |
|
3,032,111 |
|
|
Diagnostic |
|
732,369 |
|
691,701 |
|
716,838 |
|
|
Hospital |
|
105,649 |
|
102,251 |
|
96,245 |
|
|
Bio supplies |
|
66,791 |
|
57,239 |
|
24,466 |
|
|
Others |
|
18,263 |
|
34,601 |
|
90,289 |
|
|
Intersegments |
|
(34,784 |
) |
(31,386 |
) |
(25,386 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
4,318,073 |
|
4,049,830 |
|
3,934,563 |
|
|
|
|
|
|
|
|
|
|
As a result of the creation of Bio Supplies segment and Intersegment, the Group has reviewed the allocation of balances and transactions by segments. The comparative figures for years 2016 and 2015 have been restated accordingly.
The geographical distribution of net consolidated revenues is as follows:
|
|
|
Thousands of Euros |
|
||||
|
|
|
31/12/2017 |
|
31/12/2016 |
|
31/12/2015 |
|
|
USA and Canada |
|
2,896,505 |
|
2,707,579 |
|
2,604,315 |
|
|
Spain |
|
242,894 |
|
225,273 |
|
216,548 |
|
|
European Union |
|
444,089 |
|
426,223 |
|
456,919 |
|
|
Rest of the world |
|
734,585 |
|
690,755 |
|
656,781 |
|
|
|
|
|
|
|
|
|
|
|
Consolidated |
|
4,318,073 |
|
4,049,830 |
|
3,934,563 |
|
|
|
|
|
|
|
|
|
|
Details of discounts and other reductions in gross income are as follows:
|
|
|
Thousands of Euros |
|
||||
|
|
|
31/12/2017 |
|
31/12/2016 |
|
31/12/2015 |
|
|
Gross sales |
|
5,322,618 |
|
4,882,615 |
|
4,579,759 |
|
|
Chargebacks |
|
(826,775 |
) |
(652,564 |
) |
(488,072 |
) |
|
Cash discounts |
|
(57,512 |
) |
(51,953 |
) |
(46,150 |
) |
|
Volume rebates |
|
(43,274 |
) |
(51,242 |
) |
(49,458 |
) |
|
Medicare and Medicaid |
|
(41,722 |
) |
(47,820 |
) |
(25,710 |
) |
|
Other discounts |
|
(35,262 |
) |
(29,206 |
) |
(35,806 |
) |
|
|
|
|
|
|
|
|
|
|
Net sales |
|
4,318,073 |
|
4,049,830 |
|
3,934,563 |
|
|
|
|
|
|
|
|
|
|
Movement in discounts and other reductions in gross income during 2015 were as follows:
|
|
|
Thousands of Euros |
|
||||||||||
|
|
|
Chargebacks |
|
Cash |
|
Volume |
|
Medicare / |
|
Other |
|
Total |
|
|
Balance at 31 December 2014 |
|
58,431 |
|
4,738 |
|
21,030 |
|
14,823 |
|
3,174 |
|
102,196 |
|
|
Current estimate related to sales made in current and prior year |
|
488,072 |
|
46,150 |
|
49,458 |
|
25,710 |
|
35,806 |
|
645,196 |
(1) |
|
(Actual returns or credits in current period related to sales made in current period) |
|
(428,041 |
) |
(44,867 |
) |
(18,211 |
) |
(18,402 |
) |
(34,059 |
) |
(543,580 |
)(2) |
|
(Actual returns or credits in current period related to sales made in prior periods) |
|
— |
|
(246 |
) |
(25,051 |
) |
(11,257 |
) |
(1,791 |
) |
(38,345 |
)(3) |
|
Translation differences |
|
7,716 |
|
127 |
|
2,454 |
|
1,594 |
|
2,237 |
|
14,128 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December 2015 |
|
126,178 |
|
5,902 |
|
29,680 |
|
12,468 |
|
5,367 |
|
179,595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Movement in discounts and other reductions to gross income during 2016 were as follows:
|
|
|
Thousands of Euros |
|
||||||||||
|
|
|
Chargebacks |
|
Cash |
|
Volume |
|
Medicare / |
|
Other |
|
Total |
|
|
Balance at 31 December 2015 |
|
126,178 |
|
5,902 |
|
29,680 |
|
12,468 |
|
5,367 |
|
179,595 |
|
|
Current estimate related to sales made in current and prior year |
|
652,564 |
|
51,953 |
|
51,242 |
|
47,820 |
|
29,206 |
|
832,785 |
(1) |
|
(Actual returns or credits in current period related to sales made in current period) |
|
(693,458 |
) |
(51,733 |
) |
(27,409 |
) |
(24,988 |
) |
(27,243 |
) |
(824,831 |
)(2) |
|
(Actual returns or credits in current period related to sales made in prior periods) |
|
— |
|
(248 |
) |
(27,732 |
) |
(14,401 |
) |
(2,986 |
) |
(45,367 |
)(3) |
|
Translation differences |
|
1,965 |
|
758 |
|
726 |
|
858 |
|
98 |
|
4,405 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December 2016 |
|
87,249 |
|
6,632 |
|
26,507 |
|
21,757 |
|
4,442 |
|
146,587 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Movement in discounts and other reductions to gross income during 2017 were as follows:
|
|
|
Thousands of Euros |
|
||||||||||
|
|
|
Chargebacks |
|
Cash |
|
Volume |
|
Medicare / |
|
Other |
|
Total |
|
|
Balance at 31 December 2016 |
|
87,249 |
|
6,632 |
|
26,507 |
|
21,757 |
|
4,442 |
|
146,587 |
|
|
Current estimate related to sales made in current and prior year |
|
826,775 |
|
57,512 |
|
43,274 |
|
41,722 |
|
35,262 |
|
1,004,545 |
|
|
(Actual returns or credits in current period related to sales made in current period) |
|
(795,449 |
) |
(52,270 |
) |
(28,976 |
) |
(28,198 |
) |
(26,072 |
) |
(930,965 |
)(2) |
|
(Actual returns or credits in current period related to sales made in prior periods) |
|
31 |
|
(6,024 |
) |
(20,210 |
) |
(16,659 |
) |
(2,864 |
) |
(45,726 |
)(3) |
|
Translation differences |
|
(12,716 |
) |
(736 |
) |
(2,604 |
) |
(2,418 |
) |
(625 |
) |
(19,099 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December 2017 |
|
105,890 |
|
5,114 |
|
17,991 |
|
16,204 |
|
10,143 |
|
155,342 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Net impact in income statement: estimate for the current year plus prior years’ adjustments. Adjustments made during the year corresponding to prior years’ estimates have not been significant. |
|
(2) |
Amounts credited and posted against provisions for current period |
|
(3) |
Amounts credited and posted against provisions for prior period |